[Genome-wide association study for Osteoporosis].

Area of Science:

• Genetics
• Bone Biology
• Osteoporosis Research

Background:

• Osteoporosis is a significant health concern with a substantial genetic component.
• Genome-wide association studies (GWAS) have been instrumental in identifying genetic factors influencing bone mineral density (BMD) and fracture risk.

Purpose of the Study:

• To review and summarize the findings of genetic studies, particularly GWAS, related to osteoporosis.
• To highlight key genetic pathways and novel genes implicated in osteoporosis susceptibility.
• To assess the utility of current genetic risk scores in predicting osteoporosis and fracture.

Main Methods:

• Analysis of large-scale genome-wide association studies (GWAS) and meta-analyses.
• Identification and clustering of single nucleotide polymorphisms (SNPs) within relevant biological pathways.
• Review of genetic risk scores developed based on BMD-associated SNPs.

Main Results:

• Numerous SNPs associated with low BMD and fracture risk have been identified, clustering in pathways like RANK signaling, stem cell differentiation, ossification, and Wnt signaling.
• Novel osteoporosis susceptibility genes, including FONG, WDSOF1, and GPR98, have been discovered in Japanese populations.
• Existing genetic loci explain approximately 5% of the genetic variance in BMD, and current genetic risk scores show limited predictive ability for osteoporosis and fracture when BMD is known.

Conclusions:

• Genetic factors play a crucial role in osteoporosis, with identified SNPs and pathways offering insights into disease mechanisms.
• Despite advances, the predictive value of current genetic risk scores for osteoporosis and fracture remains limited, especially in the context of known BMD.
• Further research is needed to enhance the predictive accuracy of genetic assessments for osteoporosis.